logo
  

Gilead Sciences Inc. Q2 adjusted earnings Beat Estimates

Below are the earnings highlights for Gilead Sciences Inc. (GILD):

-Earnings: $1.52 billion in Q2 vs. -$3.34 billion in the same period last year.
-EPS: $1.21 in Q2 vs. -$2.66 in the same period last year.
-Excluding items, Gilead Sciences Inc. reported adjusted earnings of $2.35 billion or $1.87 per share for the period.
-Analysts projected $1.73 per share
-Revenue: $6.22 billion in Q2 vs. $5.14 billion in the same period last year.

-Guidance:
Full year EPS guidance: $6.90 - $7.25
Full year revenue guidance: $24.4 - $25.0 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT